4 Results for "

Pyrazole-based inhibitors

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "Pyrazole-based inhibitors" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-111108
CAS No.: 1964515-43-2
Purity:  99.84%
Target:  

Lactate Dehydrogenase

Research Areas:  

Cancer

LDH-IN-1 is a novel pyrazole-based inhibitor of human lactate dehydrogenase (LDH) with IC50s of 32 and 27 nM for LDHA and LDHB, respectively.
loading...
    loading...
Cat. No.: HY-11088
CAS No.: 887702-61-6
Research Areas:  

Metabolic Disease

PF-3052334 is an orally active, hepatically selective HMG-CoA reductase inhibitor with an IC50 of 1.9 nM. PF-3052334 inhibits cholesterol synthesis, with IC50 values ​​of 0.9 and 730 nM in hepatocytes and muscle cells, respectively. PF-3052334 can be used to study hypercholesterolemia .
loading...
    loading...
Cat. No.: HY-159565
Target:  

Bacterial VEGFR

Research Areas:  

Infection

VEGFR-2/InhA-IN-1 is a pyrazole-based dual inhibitor of InhA-VEGFR with anti-tuberculosis and anti-angiogenic activities. VEGFR-2/InhA-IN-1 has good antibacterial activity against Mycobacterium tuberculosis H37Rv strain (MIC=6.25 μg/mL) and significantly inhibits VEGFR-2 (IC50=15.27 nM) .
loading...
    loading...
Cat. No.: HY-111108R
CAS No.: 1964515-43-2
Research Areas:  

Cancer

LDH-IN-1 (Standard) is the analytical standard of LDH-IN-1 (HY-111108). This product is intended for research and analytical applications. LDH-IN-1 is a novel pyrazole-based inhibitor of human lactate dehydrogenase (LDH) with IC50s of 32 and 27 nM for LDHA and LDHB, respectively.
loading...
    loading...